Home > Healthcare > Drug Device Combination > Therapeutic Systems > Anal Fistula Surgical Treatment Market

Anal Fistula Surgical Treatment Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

  • Report ID: GMI4295

Anal Fistula Surgical Treatment Market Size

Anal Fistula Surgical Treatment Market size is projected to expand at a substantial rate between 2024 and 2032 driven by the rising cases of Crohn's disease, tuberculosis, and STDs. High prevalence of chronic diarrhea in emerging economies is driving the demand for fistula repair procedures. Anal fistula is a common benign disease that results in an infection that causes pus, swelling, and agony and it mostly occurs due to the development of an abscess in an anal gland. Surgical procedures like seton methods, fistulotomy, bioprosthetic plugs, and advancement flap procedures are used to treat this condition. An increase in the number of patients with IBD (inflammatory bowel disease) and the rising healthcare spending will support the adoption of advanced surgical fistula treatment options.
 

Furthermore, surgeons and healthcare providers are focusing on developing innovative surgical techniques and technologies for improved patient outcomes. Collaborations and partnerships between medical institutions and pharmaceutical companies are driving R&D efforts leading to the introduction of new surgical devices and treatment modalities.
 

For instance, in February 2024, the U.K.'s National Institute for Health and Care Research provided a $1.1 million grant to a group of professionals to develop a device for treating anal fistula. However, the limited patient awareness, challenges in accurate diagnosis, reimbursement uncertainties, and the risk of post-operative complications may lead to hindered market expansion.
 

Anal Fistula Surgical Treatment Market Trends

Innovations, such as minimally invasive procedures, laser therapy, and tissue sealants to improve surgical outcomes and patient recovery. Advanced imaging techniques like MRI and endoanal ultrasound aid in accurate diagnosis and treatment planning. Additionally, the development of sphincter-preserving techniques is enhancing post-operative continence. Surgeons and healthcare providers are embracing these advancements, leading to higher success rates, reduced complications, and improved patient satisfaction.
 

Anal Fistula Surgical Treatment Market Analysis

The fistulotomy segment is expected to account for a major share of the anal fistula surgical treatment industry by 2032. Fistulotomy is a procedure used to remove fluid and pus from fistulated tissues so that they can heal. Medical practitioners and surgeons are preferring this treatment option as it lessens damage to the anal sphincter. Additionally, benefits, such as faster healing and the ability to close abnormal gaps will boost the segment growth.
 

The anal fistula surgical treatment market from the hospitals segment is anticipated to witness high demand between 2024 and 2032. This is due to the rising anal fistula surgeries performed at hospitals as they offer comprehensive treatment facilities, skilled surgical teams, and specialized equipment for effective anal fistula management. Moreover, hospitals provide a wide range of surgical options, including minimally invasive techniques and advanced imaging capabilities for catering to diverse patient needs. Increasing patient admissions for surgical procedures coupled with advanced healthcare infrastructure in hospitals.
 

The North America anal fistula surgical treatment market is expected to grow at a notable rate from 2024-2032 due to a noticeable increase in the number of people with IBD. According to a CDC report, around 3.1 million adults in the U.S. have been diagnosed with IBD, including Crohn’s disease and ulcerative colitis. The disease constitutes chronic inflammation of the gastrointestinal tract and has prompted the need for better treatment options. Additionally, the high prevalence of AIDS in the region is increasing the uptake of sophisticated flap surgeries and seton techniques.
 

Anal Fistula Surgical Treatment Market Share

Leading anal fistula surgical treatment industry players comprise-

  • St. Mark's Hospital, Renacres Hospital
  • Bumrungrad International Hospital
  • Royal Prince Alfred Hospital
  • Hospitals Enterprise Ltd.
  • Stanford Health Care
  • Alberta Health Services
  • Fortis Healthcare
  • Sikarin Hospital
  •  

Several anal fistula surgical treatment companies are emphasizing new investments, product launches, R&D activities, and innovations to extend their business footprint. To illustrate, Fortis Healthcare emerged as a key industry player for offering specialized surgical expertise, advanced facilities, and patient-centric care.
 

Anal Fistula Surgical Treatment Industry News

  • In September 2023, Signum Surgical, a clinical-stage medical equipment business created a non-randomized, single-arm, clinical study designed to evaluate the safety and efficacy of its BioHealx device for anal fistula.

 

What Information does this report contain?

Historical data coverage: 2018 to 2023; Growth Projections: 2024 to 2032.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.
Authors: Mariam Faizullabhoy

Pre Book Now